Lv4
508 积分 2025-11-20 加入
Assessment of Efficacy Evidence for Approvals of Novel Drugs in China Between 2018 and 2022
22小时前
已完结
Assessing outcomes emerging after conversion to regular approval for cancer drug indications granted accelerated approval, 1992-2021
2天前
已完结
Two Birds With One Stone: The Protective Role of the Antidiabetic Drug Sodium‐Glucose Cotransporter‐2 Inhibitor in Neurodegenerative Diseases
6个月前
已完结
Axicabtagene Ciloleucel in Large B-Cell Lymphoma
7个月前
已完结
皖公网安备34019202002308
